Merion

Merion Biopharma is a clinical-stage biotechnology company based in Taiwan that specializes in the development of innovative drug delivery systems, particularly liposomal formulations. The company's primary focus is on oncology and pain management, utilizing its proprietary Lipo-Sol and Pulmo-Sol platforms to enhance the efficacy and reduce the toxicity of existing therapeutic agents. Their lead candidates include liposomal irinotecan for various solid tumors and specialized formulations for post-operative pain. Merion aims to address unmet medical needs by optimizing the pharmacokinetic profiles of proven drugs through advanced nanotechnology.